SciSparc Ltd. (NASDAQ:SPRC) Short Interest Update

SciSparc Ltd. (NASDAQ:SPRC) was the target of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 349,400 shares, a drop of 55.6% from the May 15th total of 786,500 shares. Currently, 3.1% of the company’s stock are short sold. Based on an average daily trading volume, of 3,790,000 shares, the days-to-cover ratio is presently 0.1 days.

SciSparc Trading Down 2.2%

NASDAQ:SPRC traded down $0.01 during trading hours on Monday, reaching $0.31. 97,417 shares of the stock were exchanged, compared to its average volume of 4,156,730. SciSparc has a twelve month low of $0.20 and a twelve month high of $1.79. The firm has a 50 day moving average of $0.31 and a 200 day moving average of $0.38.

SciSparc Company Profile

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.